Delving into the Latest Updates on Universitätsklinikum Köln with Synapse

概览

关联

1

项与 Universitätsklinikum Köln 相关的药物

Monoclonal antibody BW494(Universitätsklinikum Köln)

靶点-

作用机制

免疫刺激剂

在研机构-

原研机构

Universitätsklinikum Köln

在研适应症-

非在研适应症

胰腺癌

最高研发阶段终止

首次获批国家/地区-

首次获批日期-

148

项与 Universitätsklinikum Köln 相关的临床试验

DRKS00033674 / SuspendedN/AIIT

ADAPT-HEAT - Adaption of drug therapy during hot seasons - ADAPT-HEAT

开始日期2024-10-01

申办/合作机构

Universitätsklinikum Köln

DRKS00029301 / SuspendedN/AIIT

Short-term effects of DBS on item memory and spatial location - Short-term effects of DBS

开始日期2024-09-02

申办/合作机构

Universitätsklinikum Köln

DRKS00033302 / RecruitingN/AIIT

Impact of a communication skills training on nurses' sensed self-efficacy (ICONS) to engage in challenging conversations with patients and the patients' families - ICONS

开始日期2024-08-27

申办/合作机构

Universitätsklinikum Köln

100 项与 Universitätsklinikum Köln 相关的临床结果

登录后查看更多信息

0 项与 Universitätsklinikum Köln 相关的专利（医药）

登录后查看更多信息

1,102

项与 Universitätsklinikum Köln 相关的文献（医药）

2024-10-01·Medizinische Klinik - Intensivmedizin und Notfallmedizin

Prähospitale Leichenschau

Article

作者: Froch-Cortis, Judith ; Rothschild, Markus A

The obligatory post-mortem examination and the issuing of a death certificate are among the more unpopular medical tasks. Nevertheless, the legislature has entrusted the medical profession with a socially important task that should be carried out carefully. The examining physician decides whether the death remains a private matter or whether an official death investigation should first shed light on the circumstances of the death. The post-mortem examination system is the only instrument for the systematic detection of homicide offences. The prerequisite for issuing a death certificate is a carefully conducted external post-mortem examination, which must be carried out in full at least when certifying a natural or unexplained cause of death. In addition, the medical information on the death certificate serves epidemiological and health policy purposes and contains important information on infection control.

2024-10-01·Zeitschrift für Orthopädie und Unfallchirurgie

Vergleich der Lebensqualität nach operativer Therapie einer vertebralen Osteomyelitis und degenerativer Spondylolisthesis

Article

作者: Eysel, Peer ; Yagdiran, Ayla ; Beyer, Frank ; Bredow, Jan

2024-10-01·Die Urologie

Klassische Chemotherapie, Immuntherapie oder adjuvante Strahlentherapie – Wie können wir die onkologischen Ergebnisse der radikalen Zystektomie verbessern?

Review

作者: Paffenholz, Pia ; Zschäbitz, Stefanie

According to current guidelines, patients with muscle-invasive urothelial carcinoma (pT2-pt4a pN0) should be offered neoadjuvant cisplatin-containing chemotherapy before radical cystectomy. If not used neoadjuvantly, chemotherapy can be administered in the adjuvant setting (for > pT3 or pN+ disease). Both neoadjuvant and adjuvant therapy lead to improved overall survival. In the adjuvant setting, the checkpoint inhibitor nivolumab has also been approved for treatment of PD-L1-positive tumors (tumor proportion score [TPS] ≥ 1%). On the one hand, real-world evidence shows that cisplatin-fit patients often do not receive chemotherapy and, on the other hand, that a relevant proportion of patients are also not suitable for cisplatin-based chemotherapy. Further multimodal therapeutic strategies are hence urgently needed to improve the prognosis of affected patients. In particular, the use of antibody-drug conjugates and combination strategies involving checkpoint inhibitors are currently being intensively researched.

100 项与 Universitätsklinikum Köln 相关的药物交易

登录后查看更多信息

100 项与 Universitätsklinikum Köln 相关的转化医学

登录后查看更多信息